More than 30,000 Transvaginal mesh (TVM) lawsuits have been filed in the United States District Court, Southern District of West Virginia in Multi-District Litigation (MDL). An MDL consolidates all litigation, so that it can be efficiently litigated at the same time by all the parties in front of one Judge. For example, I filed numerous TVM cases in Arizona, which were transferred to the MDL in West Virginia. The Defendants in these cases are transvaginal mesh manufacturers C.R. Bard, Ethicon, Inc. (Johnson & Johnson), American Medical Systems, Inc., Coloplast Corporation, Cook Medical Inc. and Boston Scientific Corporation, and an MDL has been formed for cases against each manufacturer. Additionally, several thousand TVM cases are pending in state courts around the country.
Lipitor is one of the most common brand name medications on the market. According to several lawsuits filed in 2013, Pfizer, the manufacturer of Lipitor, knew or reasonably should have known in 1997 that there was a connection between Lipitor and diabetes before the drug was placed on the market; however, there was no warning placed on the label until 2012.
Transvaginal mesh (TVM) cases are being litigated in a series of Multi-District Litigations (MDL) in the United States District Court, Southern District of West Virginia. An MDL consolidates all litigation, so that it can be efficiently litigated at the same time by all the parties in front of one Judge. For example, I filed a number of TVM cases in Arizona, which were transferred to the MDL in West Virginia. The Defendants in these cases are transvaginal mesh manufacturers C.R. Bard, Ethicon, Inc. (Johnson & Johnson), American Medical Systems, Inc., Coloplast Corporation and Boston Scientific Corporation. Over 1,000 cases to date have been consolidated in West Virginia.
Stephen I. Leshner was recently selected by his peers for inclusion in The Best Lawyers in America© 2014 in the field of Plaintiffs' Personal Injury Litigation (Copyright 2013 by Woodward/White, Inc., of Aiken, SC).
Lipitor is the brand name of a popular prescription drug designed to treat high cholesterol.The U.S. Food and Drug Administration (FDA) approved Lipitor in 1996; it is prescribed in 10 mg to 80 mg tablets that are taken daily.
Phoenix, Arizona personal injury and product liability attorney Stephen I. Leshner, along with Minneapolis attorneys Johnson Becker filed a lawsuit on July 18, 2011 in Arizona Federal District Court for a patient claiming damages for injuries caused by a failed Zimmer NexGen implant.
Mothers prescribed the antidepressant prescription drug Zoloft early in their pregnancy (first trimester) are at risk for having babies with major birth defects, including:1.cardiac defects such as atrial or septal heart defects (holes in the heart), malformations, and obstructions;2.cleft lip;3.cleft palate;4.gastrointestinal malformations;5.genital malformations;6.omphalocele (an abdominal wall defect at the base of the umbilical cord which can result in the infant being born with a sac protruding through the defect that contains the small intestine, liver, and/or and large intestine);7.craniosyntosis (a defect that causes an abnormally shaped head);8.anal atresia (a defect that causes a malformed rectum); and9.spina bifida(adefect in which the backbone and spinal canal do not close before birth)
Stephen I. Leshner, a Phoenix plaintiffs personal injury, accident and medical malpractice attorney has been named to the Arizona Super Lawyerslist as one of the top attorneys in Arizona for 2013. This is the sixth consecutive year Steve has been so honored. No more than 5 percent of the lawyers in Arizona are selected by Super Lawyers.
In March of this year, the New York Times published an article about the high early failure rate of DePuy's ASR hip replacement. Since that article was published, many more reports of failures of ASR hip replacements have been received by both DePuy and the United States Food and Drug Administration. In its article, the New York Times quoted orthopedic experts critical of the design of the ASR hip replacement. Experts were also critical of DePuy's failure to stop sales of the device sooner.